Supernus Pharmaceuticals | SUPN - 普通股股本

金融业

USD 26.16

USD 1.4B

现金及等价物

USD 175.88M

USD 59M

USD 711.22M

USD 285.4M

USD 40.17M

USD -21.04M

USD 55.6M

674

EPS每股收益

USD 0.35

股本和储备

USD 1.06B

USD 176.53M

债务利息支出

USD 718K

USD 2.63M

USD 400.38M

USD 1.43B

USD -58.37M

USD 1.06B

USD -21.04M

普通股股本

USD 58.16M

72.26

USD 22.71M

USD 226.8M

销售和管理费用

USD 133.64M

USD 113.24M

贸易债权人

USD 8.52M

应收帐款人

USD 211.66M

	普通股股本	更改		日
Abbott	USD 1.74B		2.94M	2026-03
ANI Pharmaceuticals	USD 22.49M		760K	2025-12
Aurora Cannabis	CAD 63.31M		4.36M	2026-06
Bristol-Myers Squibb	USD 2.04B		7M	2026-06
Canopy Growth	CAD 422.07M		53.78M	2026-03
Cara Therapeutics	USD 9.38M		2.01K	2026-03
Corcept Therapeutics	USD 109.36M		1.44M	2026-09
Eisai	JPY 282.46M		345K	2026-06
Eli Lilly	USD 943.5M		3.33M	2026-03
Novo Nordisk	DKK 4.43B		13.25M	2026-06
Pacira	USD 39.82M		512K	2026-06
Perrigo	USD 138.8M		700K	2026-09
Pfizer	USD 5.7B		0	2026-06
Supernus Pharmaceuticals	USD 58.16M		124K	2026-06
United Therapeutics	USD 42.38M		295K	2026-09
Xeris Pharmaceuticals	USD 173.59M		1.03M	2026-06